Evidence map›Paper›PMID 27807226›Full record

ArticleJournal of virology2017

Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.

M T Sánchez-Aparicio, J Ayllón, A Leo-Macias, T Wolff, A García-Sastre

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

M T Sánchez-AparicioDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
J AyllónDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
A Leo-MaciasThe Leon H. Charney Division of Cardiology, New York University School of Medicine (NYU-SoM), New York, New York, USA.
T WolffDivision of Influenza Viruses and Other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.
A García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA adolfo.garcia-sastre@mssm.edu.
Icahn School of Medicine at Mount Sinai · USNew York University · USRobert Koch Institute · DE

Funding

Project I: Immunity to Influenza in Primary Lung Epithelial CellsU19AI117873 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SEALFON, STUART C. · 2015 to 2019
$8.6M
Spinning Disk Confocal MicroscopeS10RR024745 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FRIEDRICH, VICTOR LOUIS · 2009 to 2009
$500k
NCRR NIH HHS S10 RR024745NIAID NIH HHS HHSN272201400008CNIAID NIH HHS U19 AI117873
6 · The paper itself

Abstract

The retinoic acid-inducible gene 1 (RIG-I) signaling pathway is essential for the recognition of viruses and the initiation of host interferon (IFN)-mediated antiviral responses. Once activated, RIG-I interacts with polyubiquitin chains generated by TRIM25 and binds mitochondrial antiviral signaling protein (MAVS), leading to the production of type I IFN. We now show specific interactions among these key partners in the RLR pathway through the use of bimolecular fluorescence complementation (BiFC) and super-resolution microscopy. Dimers of RIG-I, TRIM25, and MAVS localize into different compartments. Upon activation, we show that TRIM25 is redistributed into cytoplasmic dots associated with stress granules, while RIG-I associates with TRIM25/stress granules and with mitochondrial MAVS. In addition, MAVS competes with TRIM25 for RIG-I binding, and this suggests that upon TRIM25-mediated activation of RIG-I, RIG-I moves away from TRIM25 to interact with MAVS at the mitochondria. For the first time, the distribution of these three proteins was analyzed at the same time in virus-infected cells. We also investigated how specific viral proteins modify some of the protein complexes in the pathway. The protease NS3/4A from hepatitis C virus redistributes the complexes RIG-I/MAVS and MAVS/MAVS but not RIG-I/TRIM25. In contrast, the influenza A virus NS1 protein interacts with RIG-I and TRIM25 in specific areas in the cell cytoplasm and inhibits the formation of TRIM25 homocomplexes but not the formation of RIG-I/TRIM25 heterocomplexes, preventing the formation of RIG-I/MAVS complexes. Thus, we have localized spatially in the cell different complexes formed between RIG-I, TRIM25, and MAVS, in the presence or absence of two viral IFN antagonistic proteins. IMPORTANCE: The first line of defense against viral infections is the innate immune response. Viruses are recognized by pathogen recognition receptors, such as the RIG-I like receptor family, that activate a signaling cascade that induces IFN production. In the present study, we visualized, for the first time in cells, both in overexpression and endogenous levels, complexes formed among key proteins involved in this innate immune signaling pathway. Through different techniques we were able to analyze how these proteins are distributed and reorganized spatially within the cell in order to transmit the signal, leading to an efficient antiviral state. In addition, this work presents a new means by how, when, and where viral proteins can target these pathways and act against the host immune system in order to counteract the activation of the immune response.

Indexed as

Adaptor Proteins, Signal TransducingCell LineDEAD Box Protein 58DEAD-box RNA HelicasesHost-Pathogen InteractionsHumansImmunity, InnateIntracellular SpaceMultiprotein ComplexesNucleoside-TriphosphataseProtein BindingProtein MultimerizationProtein TransportSerine EndopeptidasesSignal TransductionTranscription FactorsAdaptor Proteins, Signal TransducingDEAD Box Protein 58DEAD-box RNA HelicasesINS1 protein, influenza virusMAVS protein, humanMultiprotein ComplexesNS3 protein, hepatitis C virusNS4 protein, hepatitis C virusNucleoside-TriphosphataseSerine EndopeptidasesTranscription FactorsTRIM25 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesViral Nonstructural ProteinsViral Proteasesinfluenzainnate immunitymicroscopypathogen recognition receptorsRIG-Ivirus

Identifiers

PMID27807226
PMCPMC5215348
OpenAlexW2548830355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.